05/13/2025
3:20 PM | Evoke Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/10/2025
3:30 PM | Evoke Pharma (Filer)
| Form DEF 14A | |
04/10/2025
3:35 PM | Evoke Pharma (Filer)
| Form DEFA14A | |
04/10/2025
3:40 PM | Evoke Pharma (Filer)
| Form ARS | |
03/24/2025
5:47 PM | Bleichroeder LP (Filed by)
Evoke Pharma (Subject)
| Form SCHEDULE 13G/A | |
03/24/2025
3:30 PM | Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:30 PM | D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
6:15 PM | Bleichroeder LP (Filed by)
Evoke Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/24/2025
7:30 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
3:47 PM | Evoke Pharma (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13D/A | |
01/30/2025
5:39 PM | Evoke Pharma (Issuer)
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for EVOK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Evoke Pharma and its competitors with MarketBeat's FREE daily newsletter. |
01/29/2025
3:30 PM | CARLSON MARILYN R. (Reporting)
Evoke Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | Evoke Pharma (Issuer)
GARNER CAM L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | Brady Todd C (Reporting)
Evoke Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | Evoke Pharma (Issuer)
REED VICKIE S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | Evoke Pharma (Issuer)
Hill Malcolm R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | Evoke Pharma (Issuer)
WIDDER KENNETH J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:30 PM | D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:31 PM | Evoke Pharma (Issuer)
Harkey Wilmot B. (Reporting)
Mack Daniel (Reporting)
Nantahala Capital Management, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/14/2024
8:19 AM | Altium Capital Management LP (Filed by)
Evoke Pharma (Subject)
| Form SC 13G/A | |
10/29/2024
6:47 PM | Evoke Pharma (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
10/28/2024
7:10 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
4:07 PM | Evoke Pharma (Issuer)
Smeal Benjamin C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
4:09 PM | Evoke Pharma (Issuer)
Smeal Benjamin C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
8:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:15 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:08 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:11 PM | Evoke Pharma (Filer)
| Form 424B3 | |
09/20/2024
6:28 PM | Evoke Pharma (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13D | |
09/08/2024
11:15 PM | Evoke Pharma (Filer)
| Form EFFECT | |
08/29/2024
3:16 PM | Evoke Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/21/2024
11:15 PM | Evoke Pharma (Filer)
| Form EFFECT | |
08/16/2024
6:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:15 AM | Evoke Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
7:20 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:11 PM | Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:48 PM | D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
6:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
6:01 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
7:00 AM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
05/30/2024
5:09 PM | Evoke Pharma (Issuer)
Kowieski Mark (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2024
3:17 PM | Evoke Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:53 PM | Brady Todd C (Reporting)
Evoke Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy EVOK Stock Free EVOK Stock Alerts